164 related articles for article (PubMed ID: 15465757)
21. Evaluation of the preventive effect of isoflavone extract on bone loss in ovariectomized rats.
Lee YB; Lee HJ; Kim KS; Lee JY; Nam SY; Cheon SH; Sohn HS
Biosci Biotechnol Biochem; 2004 May; 68(5):1040-5. PubMed ID: 15170107
[TBL] [Abstract][Full Text] [Related]
22. Role of soy protein with normal or reduced isoflavone content in reversing bone loss induced by ovarian hormone deficiency in rats.
Arjmandi BH; Getlinger MJ; Goyal NV; Alekel L; Hasler CM; Juma S; Drum ML; Hollis BW; Kukreja SC
Am J Clin Nutr; 1998 Dec; 68(6 Suppl):1358S-1363S. PubMed ID: 9848499
[TBL] [Abstract][Full Text] [Related]
23. Effect of daidzein, a soy isoflavone, on bone metabolism in Cd-treated ovariectomized rats.
Om AS; Shim JY
Acta Biochim Pol; 2007; 54(3):641-6. PubMed ID: 17717607
[TBL] [Abstract][Full Text] [Related]
24. Possible role of S-equol on bone loss via amelioration of inflammatory indices in ovariectomized mice.
Nishide Y; Tadaishi M; Kobori M; Tousen Y; Kato M; Inada M; Miyaura C; Ishimi Y
J Clin Biochem Nutr; 2013 Jul; 53(1):41-8. PubMed ID: 23874069
[TBL] [Abstract][Full Text] [Related]
25. Droloxifene does not blunt bone anabolic effects of prostaglandin E2, but maintains prostaglandin E2-restored bone in aged, ovariectomized rats.
Ke HZ; Crawford DT; Qi H; Pirie CM; Simmons HA; Chidsey-Frink KL; Chen HK; Jee WS; Thompson DD
Bone; 1999 Jan; 24(1):41-7. PubMed ID: 9916783
[TBL] [Abstract][Full Text] [Related]
26. Hesperidin, a citrus flavonoid, inhibits bone loss and decreases serum and hepatic lipids in ovariectomized mice.
Chiba H; Uehara M; Wu J; Wang X; Masuyama R; Suzuki K; Kanazawa K; Ishimi Y
J Nutr; 2003 Jun; 133(6):1892-7. PubMed ID: 12771335
[TBL] [Abstract][Full Text] [Related]
27. Bone-sparing effect of soy protein in ovarian hormone-deficient rats is related to its isoflavone content.
Arjmandi BH; Birnbaum R; Goyal NV; Getlinger MJ; Juma S; Alekel L; Hasler CM; Drum ML; Hollis BW; Kukreja SC
Am J Clin Nutr; 1998 Dec; 68(6 Suppl):1364S-1368S. PubMed ID: 9848500
[TBL] [Abstract][Full Text] [Related]
28. Combined effects of physical activity, dietary isoflavones and 17beta-estradiol on movement drive, body weight and bone mineral density in ovariectomized female rats.
Hertrampf T; Degen GH; Kaid AA; Laudenbach-Leschowsky U; Seibel J; Di Virgilio AL; Diel P
Planta Med; 2006 May; 72(6):484-7. PubMed ID: 16773530
[TBL] [Abstract][Full Text] [Related]
29. Serum equol, bone mineral density and biomechanical bone strength differ among four mouse strains.
Ward WE; Kim S; Chan D; Fonseca D
J Nutr Biochem; 2005 Dec; 16(12):743-9. PubMed ID: 16098733
[TBL] [Abstract][Full Text] [Related]
30. The synthetic phytoestrogen, ipriflavone, and estrogen prevent bone loss by different mechanisms.
Arjmandi BH; Birnbaum RS; Juma S; Barengolts E; Kukreja SC
Calcif Tissue Int; 2000 Jan; 66(1):61-5. PubMed ID: 10602847
[TBL] [Abstract][Full Text] [Related]
31. Puerariae radix prevents bone loss in ovariectomized mice.
Wang X; Wu J; Chiba H; Umegaki K; Yamada K; Ishimi Y
J Bone Miner Metab; 2003; 21(5):268-75. PubMed ID: 12928827
[TBL] [Abstract][Full Text] [Related]
32. Skeletal effects of parathyroid hormone infusion in ovariectomized rats with or without estrogen repletion.
Shen V; Birchman R; Wu DD; Lindsay R
J Bone Miner Res; 2000 Apr; 15(4):740-6. PubMed ID: 10780865
[TBL] [Abstract][Full Text] [Related]
33. Equol but not genistein improves early metaphyseal fracture healing in osteoporotic rats.
Kolios L; Sehmisch S; Daub F; Rack T; Tezval M; Stuermer KM; Stuermer EK
Planta Med; 2009 Apr; 75(5):459-65. PubMed ID: 19241330
[TBL] [Abstract][Full Text] [Related]
34. The phytoestrogen genistein reduces bone loss in short-term ovariectomized rats.
Fanti P; Monier-Faugere MC; Geng Z; Schmidt J; Morris PE; Cohen D; Malluche HH
Osteoporos Int; 1998; 8(3):274-81. PubMed ID: 9797913
[TBL] [Abstract][Full Text] [Related]
35. Isoflavone metabolism and bone-sparing effects of daidzein-metabolites.
Uehara M
J Clin Biochem Nutr; 2013 May; 52(3):193-201. PubMed ID: 23704808
[TBL] [Abstract][Full Text] [Related]
36. Comparative effects of droloxifene, tamoxifen, and estrogen on bone, serum cholesterol, and uterine histology in the ovariectomized rat model.
Ke HZ; Chen HK; Simmons HA; Qi H; Crawford DT; Pirie CM; Chidsey-Frink KL; Ma YF; Jee WS; Thompson DD
Bone; 1997 Jan; 20(1):31-9. PubMed ID: 8988345
[TBL] [Abstract][Full Text] [Related]
37. [Effect of estrogen on the expression of matrix GLA protein in ovariectomized SD rats].
Chen XY; Jiang XH; Lai XY; Fang XN; Yang Y
Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):833-8. PubMed ID: 23302124
[TBL] [Abstract][Full Text] [Related]
38. Synergistic Effects of Genistein and Zinc on Bone Metabolism and the Femoral Metaphyseal Histomorphology in the Ovariectomized Rats.
Qi S
Biol Trace Elem Res; 2018 Jun; 183(2):288-295. PubMed ID: 28842860
[TBL] [Abstract][Full Text] [Related]
39. Droloxifene, a new estrogen antagonist/agonist, prevents bone loss in ovariectomized rats.
Ke HZ; Simmons HA; Pirie CM; Crawford DT; Thompson DD
Endocrinology; 1995 Jun; 136(6):2435-41. PubMed ID: 7750465
[TBL] [Abstract][Full Text] [Related]
40. Prevention of corticosteroid-induced bone loss with alendronate.
Wimalawansa SJ; Simmons DJ
Proc Soc Exp Biol Med; 1998 Feb; 217(2):162-7. PubMed ID: 9452139
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
